![Peizhi Luo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peizhi Luo
Chief Executive Officer at
ADAGENE INC.
Net worth: 34 M $ as of 2026-07-30
Profile
Pei Zhi Luo is the Chairman & Chief Executive Officer of Adagene, Inc., a company he founded in 2011.
He is also the President, Director & Chief Technology Officer of Abmaxis, Inc., a company he founded in 2000.
Dr. Luo previously worked as a Director-Biologics Technology at Merck & Co., Inc. and as a Scientist at Xencor, Inc. He received his undergraduate degree from Peking University in 1986, his doctorate degree from The University of Chicago in 1995, and his graduate degree from the Chinese Academy of Sciences in 1989.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ADAGENE, INC. 21.1% | 2026-08-05 | 11,476,530 ( 21.1% ) | 34 M $ | 2026-07-30 |
Peizhi Luo active positions
| Companies | Position | Start |
|---|---|---|
| ADAGENE INC. | Chief Executive Officer | 2011-10-31 |
Former positions of Peizhi Luo
| Companies | Position | End |
|---|---|---|
Abmaxis, Inc.
 Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Founder | 2008-11-05 |
| XENCOR, INC. | Corporate Officer/Principal | 2000-07-31 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Training of Peizhi Luo
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
95
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Abmaxis, Inc.
Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Peking University
 Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chinese Academy of Sciences
 Chinese Academy of Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adagene, Inc.
 Adagene, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which discovers and develops novel antibody-based cancer immunotherapies | Health Technology |
- Stock Market
- Insiders
- Peizhi Luo
